BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

The CementBloc and Novartis Vaccines and Diagnostics (NVS) to Jointly Present Top Considerations in Interactive Selling at the 11th Annual iPharmaConnect


3/22/2012 9:50:18 AM

NEW YORK, March 21, 2012 /PRNewswire/ -- Meghan Lopresto, VP, Sales Force Automation Analytics at The CementBloc, and Emad Abdelnaby, Director of Marketing at Novartis Vaccines, will be co-presenting their expertise in interactive selling at CBI's iPharmaConnect plenary session on March 27, 2012, in Philadelphia.

The conference is a 3-day symposium that will unite senior-level marketing, digital, brand, and medical affairs professionals to discuss novel approaches to thriving multichannel digital campaigns. From the client and agency perspectives, Ms. Lopresto and Mr. Abdelnaby will be presenting the success story behind the recently rolled-out program at Novartis Vaccines. Their talk, entitled, "Develop a Road Map for Transforming Your Organization Through Interactive Selling" will serve as an essential blueprint for optimizing iPad selling across an organization.

"Transitioning your field sales team over to an iPad platform is more than just an upgrade of their technology," says Ms. Lopresto. "It represents a key shift in the engagement between sales representatives and their customers. A successful rollout of these new tools requires a defined road map of the process, including agreed-upon core principles and buy-in from multiple stakeholders. If this is achieved, an organization can be transformed, for the better, through interactive selling."

At The CementBloc, Ms. Lopresto plays a key role in interactive selling tool development and measurement, multichannel marketing planning and analytics, promotional spend optimization, CRM/PRM, and closed-loop marketing initiatives. For more than 10 years, Meghan has been in the pharmaceutical industry in leadership roles, providing clients with innovative solutions for multichannel and professional advertising campaigns.

As Director of Marketing for the US Meningococcal Franchise at Novartis Vaccines and Diagnostics (NVD), Mr. Abdelnaby has responsibility for the development of professionally directed strategies and resources. Through his work at Novartis, Mr. Abdelnaby has helped to continue NVD's commitment to innovation in this space, including adoption of a broad-scale iPad platform for physician detailing, CRM, and sales training.

For more information or to register for iPharmaConnect, please contact CBI at 1-800-817-8601.

About The CementBloc: The CementBloc is a leading multichannel health and wellness creative agency based in New York. Founded in 2000 by Susan Miller and Rico Viray, The CementBloc is also a founding member of Indigenus, an independent global network of entrepreneurial healthcare creative agencies.

vwww.thecementbloc.com

SOURCE The CementBloc



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->